|
115 |
|
2017 |
Cost Analysis for MSC Production |
Active |
|
|
|
114 |
|
2017 |
Red Cell Antibody Production in Bone Marrow Transplants |
Active |
|
|
|
113 |
|
2017 |
Haemoglobin screening and deferral policies |
Completed |
136 |
|
|
112 |
|
2017 |
Older Donor Demographics |
Completed |
129 |
|
|
111 |
|
2017 |
Pediatric Transfusion Medicine Education |
Active |
|
|
|
110 |
|
2017 |
Titer Products for SafetY: TIPSY |
Completed |
126 |
|
|
109 |
|
2017 |
Effect of Having a Surgical RBC Schedule on the General Availability of rbcs pre-Incision: EHSS GAI |
Closed |
|
|
|
108 |
|
2017 |
Human Platelet Lysate |
Completed |
164 |
|
|
107 |
|
2017 |
Better Understanding of Mfi cut-offs for Platelet Transfusions in Refractory Patients: BUMPER |
Completed |
139 |
|
|
106 |
|
2017 |
Oneg Product Transfusion, Inventory Management and Utilization during Shortage: OPTIMUS |
Completed |
123 |
|